Urology News and Research

Latest Urology News and Research

Tips to avoid and cope with kidney stones

Summer can mean more than just an increase in temperatures, humidity and outdoor physical activity. It can also mean an increased risk of kidney stones, which affect approximately 3.8 million people in the United States and are on the rise.

8 Aug 2012

Older men with higher levels of free testosterone more likely to develop prostate cancer

New research finds older men with higher levels of free testosterone have an increased risk of prostate cancer. Australian researchers spent a decade exploring the testosterone-prostate cancer connection by comparing natural testosterone levels of men in their 70s and 80s, those with prostate cancer and without.

8 Aug 2012

Leptin polymorphism combinations influence BMI in Chinese

The presence of genetic variants in both the leptin gene and the gene for its receptor may predispose Chinese individuals to obesity, report researchers.

7 Aug 2012

The Patient Recruiting Agency announces enrollment for research study of women with IC/BPS

The Patient Recruiting Agency announces recruitment for a research study of female patients with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).

7 Aug 2012

Viewpoints: Mass. at disadvantage in cutting health costs; McDonnell says Va. can point to better way

Massachusetts will be the first state to try to cap overall health care spending, both private and public, so that it will grow no faster than the state economy. The state was able to reach near-universal coverage because the vast majority of its population was already covered by some form of insurance. It also could subsidize coverage for the uninsured using a big pool of money that had been used for charity care. But when it comes to controlling health care costs, Massachusetts has no advantage, and in fact is starting behind most other states.

7 Aug 2012

Less is definitely more for men who undergo nephrectomy

Researchers have identified a link between complete kidney removal and erectile dysfunction, a manifestation of endothelial dysfunction that often precedes cardiovascular disease.

6 Aug 2012

Adiposity linked to cognitive decline in elderly

High levels of adiposity increase rates of cognitive decline in the “young elderly” aged between 60 and 70 years, report Korean researchers.

6 Aug 2012

Empa physicist analyzes structure and composition of soot particles

Since June 2012, it is official: The World Health Organisation (WHO) has classified diesel soot as a lung carcinogen. Artur Braun, a physicist at Empa and an X-ray spectroscopy expert, has made crucial contributions to analyzing the structure and composition of soot particles.

6 Aug 2012

Rexahn announces completion of RX-3117 exploratory Phase I clinical trial in cancer patients

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed its exploratory Phase I clinical trial of RX-3117 in cancer patients.

6 Aug 2012

Qualitest confirms launch of generic Singulair Tablets for asthma and allergic rhinitis

Qualitest Pharmaceuticals today confirmed that it has launched a generic version of Singulair (montelukast sodium) Tablets and Chewable Tablets, following the expiration of the last patent that provides Merck U.S. market exclusivity. Qualitest will begin shipping the product immediately. Montelukast Sodium Tablets are labeled for use in treating symptoms of asthma and allergic rhinitis.

6 Aug 2012

Astellas announces closure of Urogenix research facility

Astellas Pharma Inc. announced that it decided to close Urogenix, Inc., an Astellas subsidiary, which is a research facility focusing on drug discovery in the field of urology.

6 Aug 2012

Depression in kidney cancer patients associated with survival and inflammatory gene regulation

Research from The University of Texas MD Anderson Cancer Center has found that symptoms of depression in patients with newly diagnosed metastatic kidney cancer are associated with survival and inflammatory gene regulation may explain this link.

3 Aug 2012

Iced tea can lead to formation of kidney stones

This is the peak season for drinking iced tea, but a Loyola University Medical Center urologist is warning the popular drink can contribute to painful kidney stones.

3 Aug 2012

Atlantic fish improves glucose and fat metabolism

Eating saury, a type of fish common to the Atlantic, has immediate beneficial effects on glucose and fat metabolism, show findings from a Japanese study.

2 Aug 2012

Serving size in the eye of the beholder

Canadian study findings suggest that many people overestimate the size of one serving of food and may overeat as a result.

2 Aug 2012

Women with vulvodynia more likely to also have other chronic pain conditions

Millions of women suffer from unexplained vulvar pain so severe it can make intercourse, exercise and even sitting unbearable. New research now shows that women with this painful vaginal condition known as vulvodynia are two to three times more likely to also have one or more other chronic pain conditions, including irritable bowel syndrome, fibromyalgia (musculoskeletal pain) and interstitial cystitis (bladder pain).

2 Aug 2012

Lipid treatment absolved of hemorrhagic transformation guilt

The lipid profiles of patients undergoing thrombolysis for acute stroke predict their mortality risk but not their risk for symptomatic intracerebral hemorrhage, shows a large study.

1 Aug 2012

Obesity also affects sexual and urinary health in men

As a man's waistline grows, so can his experience with sexual dysfunction and frequent urination, say researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The study, published in the August issue of the British Journal of Urology International (BJUI), is the first to comprehensively show that obesity in men affects not just their hearts and metabolism, but also their sexual and urinary health.

31 Jul 2012

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

31 Jul 2012